Valuation: CV Sciences, Inc.

Market Cap 4.04M 3.54M 3.28M 3.02M 5.69M 389M 5.76M 39.15M 15.32M 191M 15.16M 14.83M 658M P/E 2024
-2.48x
P/E 2025 -11.8x
Enterprise Value 5.76M 5.05M 4.68M 4.3M 8.11M 554M 8.21M 55.8M 21.84M 272M 21.61M 21.14M 938M EV / Sales 2024
0.42x
EV / Sales 2025 0.95x
Free-Float
92.21%
Yield 2024 *
-
Yield 2025 -
1 day+6.62%
1 week+36.79%
Current month+19.34%
1 month+45.00%
3 months-14.71%
6 months-34.09%
Current year-52.77%
1 week 0.02
Extreme 0.017
0.03
1 month 0.02
Extreme 0.017
0.03
Current year 0.02
Extreme 0.015
0.1
1 year 0.02
Extreme 0.015
0.1
3 years 0.02
Extreme 0.015
0.1
5 years 0.02
Extreme 0.015
0.36
10 years 0.02
Extreme 0.015
9.2
Manager TitleAgeSince
Chief Executive Officer 68 2018-05-30
Director of Finance/CFO 51 2019-03-14
Director TitleAgeSince
Director/Board Member 68 2018-05-30
Director/Board Member 56 2022-07-20
Director/Board Member 58 2022-10-20
Date Insider Type Main position Quantity % Market Cap.
2/18/25 Free

Chief Executive Officer

3,000,000 1.6281%
2/18/25 Free

Chief Financial Officer

2,350,000 1.2753%
2/18/25 Free

Director

500,000 0.2714%
Change 5-day change 1-year change 3-year change Capi.($)
+6.62%+36.79%-21.62%-41.18% 4.04M
+2.49%+1.98%+54.22%+154.40% 1,048B
+0.72%-1.28%+52.48%+47.25% 603B
+1.07%+4.62%+38.54%+78.17% 452B
+0.42%+1.30%+31.64%+22.30% 327B
+0.61%+3.18%+36.60%+38.63% 283B
+1.80%+0.83%+22.39%+17.53% 259B
-0.39%-2.27%-23.79%-41.26% 219B
+0.57%+3.09%+23.78%+55.97% 198B
-2.20%+0.18%+20.32%+61.56% 162B
Average +1.06%+1.56%+23.46%+39.34% 355.17B
Weighted average by Cap. +0.94%+1.69%+38.08%+73.34%

Financials

2024 2025
Net sales 15.7M 13.77M 12.75M 11.74M 22.14M 1.51B 22.4M 152M 59.57M 741M 58.95M 57.68M 2.56B 13.79M 12.09M 11.2M 10.31M 19.44M 1.33B 19.67M 134M 52.3M 651M 51.76M 50.65M 2.25B
Net income -2.39M -2.1M -1.94M -1.79M -3.37M -231M -3.42M -23.2M -9.08M -113M -8.99M -8.79M -390M -958K -840K -778K -716K -1.35M -92.26M -1.37M -9.29M -3.63M -45.22M -3.6M -3.52M -156M
Net Debt 325K 285K 264K 243K 458K 31.3M 464K 3.15M 1.23M 15.34M 1.22M 1.19M 52.96M 1.72M 1.51M 1.4M 1.28M 2.42M 165M 2.45M 16.65M 6.52M 81.09M 6.45M 6.31M 280M
Logo CV Sciences, Inc.
CV Sciences, Inc. is a consumer wellness company specializing in nutraceuticals and plant-based foods. The Company develops, manufactures, markets and sells herbal supplements, CBD products and plant-based food products under +PlusCBD, +PlusHLTH, Cultured Foods, and Lunar Fox brands in the healthcare market sector, including nutraceutical, beauty care, specialty foods, and pet products. Its hemp extracts, and other science-backed, natural ingredients and products are sold through a range of sales channels from business-to-business (B2B) to business-to-consumer (B2C). Its +PlusCBD line of products are available in softgels, tinctures, topicals, and gummies. Its Cultured Foods and Lunar Fox cater to individuals seeking vegan, gluten-free, or flexitarian options for a nutritious and satisfying culinary experience. Its +PlusHLTH is a line of cannabinoid-free supplements delivering targeted formulations for optimized health, improved performance and increased vitality.
Employees
43
Date Price Change Volume
26-07-21 US$0.0198 +10.00% 525,767
26-07-20 US$0.0180 -10.00% 528,130
26-07-17 US$0.0200 -2.44% 1,039,549
26-07-16 US$0.0205 +6.99% 262,469
26-07-15 US$0.0192 -9.41% 126,569
  1. Stock Market
  2. Stocks
  3. CVSI Stock